title: Patient priority in the era of patent expiries.
authors.lastname: The Lancet Oncology
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D010330:Patents as Topic; D028701:Patient Rights; D000068878:Trastuzumab; D006113:United Kingdom
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab